Intravenous ketamine: Clinical Trials

5 trials of Intravenous ketamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 active not recruiting, 1 completed, 1 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Terminated 2, Active not recruiting 1, Completed 1, Unknown 1

Follow Intravenous ketamine: new trials by email Literature Review of Intravenous ketamine trials Research Report on Intravenous ketamine

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IV and Intrathecal Ketamine in Cesarean Section
Intrathecal ketamine, Intravenous ketamine - Cesarean Section, Analgesia
Phase 4CompletedAssiut University602023-02-012025-03-06
Ketamine + Cognitive Training for Suicidality in the Medical Setting
Intravenous ketamine, Cognitive training, Sham Training - Suicide, Attempted
Phase 4Active not recruitingRebecca Price2002021-03-152026-03-24
Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot
Intravenous ketamine, Cognitive training, Sham Training - Suicide, Attempted
Phase 4TerminatedRebecca Price162019-12-192024-07-22
Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures
Intravenous Ketamine, Intranasal Ketamine - Trauma, Fractures, Closed
Phase 4TerminatedUniversity of Alabama at Birmingham402019-09-092023-04-20
Ketamine v. Ketorolac for Management of Generalized Tension Type Headache
Intravenous ketamine, Ketorolac, Normal saline - Migraine
Phase 4UnknownThe Brooklyn Hospital Center602016-02-012018-07-06

Conditions studied

Suicide, Attempted (2)  ·  Agnosia (1)  ·  Emergencies (1)  ·  Fractures, Bone (1)  ·  Fractures, Closed (1)  ·  Migraine Disorders (1)  ·  Wounds and Injuries (1)

Sponsors

Rebecca Price (2)  ·  Assiut University (1)  ·  The Brooklyn Hospital Center (1)  ·  University of Alabama at Birmingham (1)

Countries

United States (4)  ·  Egypt (1)

Top investigators

James Statler, MD (1)  ·  Judson Barber, MD (1)  ·  Rebecca B Price, PhD (1)

NIH funding

R01MH124983 (1)